Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma
Perla Chami(American University of Beirut), Carla Hajj(Memorial Sloan Kettering Cancer Center), Christopher H. Crane(Memorial Sloan Kettering Cancer Center), William R. Jarnagin(Memorial Sloan Kettering Cancer Center), Jennifer Ma(Jackson Memorial Hospital), Marsha Reyngold(Memorial Sloan Kettering Cancer Center), James J. Harding(Memorial Sloan Kettering Cancer Center), Maria El Homsi(Memorial Sloan Kettering Cancer Center), Ghassan K. Abou‐Alfa(Memorial Sloan Kettering Cancer Center), Youssef Diab(Université Gustave Eiffel), Hassan Azhari(Memorial Sloan Kettering Cancer Center), Joseph Hajj(University of Balamand), Danny N. Khalil(Memorial Sloan Kettering Cancer Center)
Cited by 19
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
|Nature Cell Biology|2015|2.7k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k